The results highlight the importance of evaluating and monitoring cognitive function in individuals with recent critical illness or major infections, especially if they are already at risk for dementia.
The FDA has taken action against 17 companies that are illegally selling unapproved and/or misbranded products that claim to prevent, treat, or cure Alzheimer disease and other serious diseases and health conditions.
Crenezumab is an investigational monoclonal antibody that preferentially binds to and promotes the removal of neurotoxic oligomers, a form of beta-amyloid.
Nearly all older adults with Down syndrome now have dementia when they die, making this a vital population to study disease progression, modifying factors, and potential treatments.
Researchers examined the safety, tolerability, and feasibility of young plasma infusion in patients with mild to moderate Alzheimer disease dementia in an Alzheimer’s symptom amelioration study.
The concomitant use of cholinesterase inhibitors or memantine was associated with an increased rate of cognitive decline in clinical trials of patients with Alzheimer disease.
Investigators analyzed medial temporal lobe structure, white matter lesion load, and β-amyloid deposition in women who underwent bilateral salpingo-oophorectomy prior to reaching natural menopause.
